Stock Evaluator: InfuSystem Holdings, Inc. (INFU)

InfuSystem Holdings, Inc. INFU

$9.34 0.20 2.19%
August 3, 2026 10:28:15 AM EST November 10, 2021 Volume: 60,817
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD AMEX | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Commentary & Analysis


Financial Summary

Share Statistics INFU Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $184.5 $1,742.7 27%
Shares Out (Mil) 20.9 76.7 31%
Institutional Ownership 91.8% 89.7% 60%
Float (Mil) 18.7 49.4 28%
Beta 1.40 0.82 79%
Avg Daily Volume (000s) 138 521 39%
Price Change
(52-week)
60.1% 78.7% 83%
Growth INFU Industry
Median
Percentile
(All Stocks)
Sales (5yr) 8.2% 11.0% 51%
Net Income (5yr) (17.5%) (0.7%) 23%
EPS (5yr) (17.3%) 3.1% 16
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (18.0%) (18.0%) 38%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS $0.072 $0.290 $0.425
Month Ago EPS na na na
# Rev Up 1 1 1
# Rev Down 0 0 0
Three Months Ago EPS na na na
Year/Year Chg 44.0% (6.5%) 75.8%
Financials INFU Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $142 $1,456 29%
Net Income (TTM) (Mil) $8 $12 45%
EPS (TTM) $0.387 $0.300 51%
Operating Cash Flow (TTM) (Mil) $24 $138 42%
Net Cash Flow (TTM) (Mil) $1 $8 46%
Long-Term Debt (Q1) (Mil) $23 $316 34%
Enterprise Value (Q1) (Mil) $208 $2,170 26%
Valuation INFU Industry
Median
Percentile
(All Stocks)
P/B 3.14 2.85 66%
P/E 24.6 26.7 60%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.1 na
Ratios INFU Industry
Median
Percentile
(All Stocks)
Gross Margin 56.7% 27.8% 69%
Net Margin 5.6% 1.1% 50%
ROA 7.8% 1.8% 82%
ROE 13.9% 7.1% 69%
Liabilities to Assets 40.5% 59.9% 31%
F-Score 8 5 94%

InfuSystem Holdings, Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors